MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
Molecular Mechanisms Controlling HIV Transcription and Latency – Implications for Therapeutic Viral Reactivation
MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
Selective miRNA Modulation Fails to Activate HIV Replication in In Vitro Latency Models: Molecular Therapy - Nucleic Acids
Development and validation of plasma miRNA biomarker signature panel for the detection of early HIV-1 infection - eBioMedicine
MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
MicroRNAs and HIV-1 Infection: Antiviral Activities and Beyond - ScienceDirect
HIV post-treatment controllers have distinct immunological and virological features
HIV latency and RNA
The involvement of microRNAs in HCV and HIV infection - Nicky Joshi, Madhuri Chandane Tak, Anupam Mukherjee, 2022
The multifaceted nature of HIV latency. - Document - Gale OneFile: Health and Medicine
